Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Expression data from mouse endothelial cell in human ovarian cancer

ABSTRACT: Expression data from mouse endothelial cell in human ovarian cancer

PROVIDER: PRJNA749178 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Expression data from mouse endothelial cell in human ovarian cancer

Project description:To examine potential mechanisms underlying resistance to anti-VEGF antibody (AVA) therapy, we used mouse models to identify tumors that demonstrated growth subsequent to a period of initial response. Specifically, we established orthotopic mouse models of ovarian cancer designed to develop adaptive resistance after treatment with an AVA. To examine potential mechanisms underlying resistance to anti-VEGF antibody (AVA) therapy, we used mouse models to identify tumors that demonstrated growth subsequent to a period of initial response. Specifically, we established orthotopic mouse models of ovarian cancer designed to develop adaptive resistance after treatment with an AVA.

2021-07-25 | GSE180687 | GEO

Expression data from human endothelial cells co-cultured with cancer associated fibroblasts

Project description:Cancer associated fibroblasts (CAFs) have been shown to plays crucial roles in cancer progression. Although increasing evidence demonstrates that CAFs have important roles in modulating the aggressive phenotypes of cancer cells, their effects on the tumor vasculature remain underexplored. We co-cultured TIME human microvascular endothelial cells (MECs) with either primary human ovarian CAFs or normal ovarian fibroblasts (NFs) to evaluate the effects of CAFs on phenotypes of endothelial cells.

2018-02-14 | GSE106519 | GEO

Ovarian cancer mouse model tissue LC-MSMS

Project description:For this project N-glycosylated peptides were extracted from tissue of a mouse model for ovarian cancer tissue and matched control mice. The extracted N-glycosites were analyzed by LC-MSMS

2019-07-01 | PXD005665 | Pride

Expression data from ovarian cancer SKOV3 human cell line

Project description:CDCP1 and PLAGL2 have been shown to act as oncogenes in several cancer types but little is known about the molecular signalling underlying these processes in ovarian cancer cells. In this study we aim to find the downstream signalling upon their individual silencing in the human ovarian cancer cell line SKOV3. We used microarrays to detail the global programme of gene expression underlying CDCP1 and PLAGL2 signalling in the human ovarian cancer cell line SKOV3

2020-04-12 | GSE113115 | GEO

Expression data from human ovarian cancer cell line

Project description:Expression data from human ovarian cancer cell line

| PRJNA479406 | ENA

Ovarian serous cancer

Project description:Ovarian serous cancer

| PRJNA117359 | ENA

Gene expression profiles of serous ovarian cancer in human and mouse

Project description:Gene expression profiles of serous ovarian cancer in human and mouse

| PRJNA140493 | ENA

Peptidome profiling of ovarian cancer and non-cancer proximal fluids: ascites and blood sera

Project description:Ovarian cancer is the most lethal gynecological malignancy, because its early detection is difficult due to the absence of recognizable physical symptoms and a lack of sensitive screening methods. Despite a large number of proteomic studies of biological fluids from ovarian cancer patients, only a few biomarkers are used in clinical practice. Low molecular weight endogenous peptides more easily diffuse across endothelial barriers and can be more relevant biomarker candidates. In this current study, detailed peptidomic analysis of 26 ovarian cancer and 15 non-cancer samples of biological fluids (ascites and sera) were performed using TripleTOF 5600+ mass-spectrometer.

2018-04-05 | PXD009382 | Pride

Estrogen regulated microRNAs in mouse ovarian cancer cells.

Project description:In a mouse model of ovarian cancer, we have established that prolonged exposure to 17β-estradiol (E2) accelerates tumour onset and increases the incidence of morphologically dysplastic ovarian surface epithelium (OSE). OSE cell proliferation and morphology are tightly regulated by the asymmetrical distribution of polarity proteins that provide positional cues for surface localization and growth inhibition. We hypothesized that E2 causes OSE dysplasia by inhibiting a tumour suppressor gene called Disabled-2 (Dab2). Dab2 is critical in mediating the polarized distribution of cell surface proteins and is highly expressed in normal OSE, but is absent in the majority of ovarian cancers. In this study, Dab2 is shown to be suppressed by E2 and we investigated the possibility that this occurs through E2 up-regulation of microRNAs. microRNA microarray analysis comparing control vs. E2 treated mouse ovarian cancer cells (MASE) was used to identify candidate miRNAs that have a seeding sequence capable of targeting the 3-prime untranslated region (3’UTR) of both human and mouse Dab2 transcript.

2017-11-30 | GSE98391 | GEO

Gene Expression Profiling in high-grade serous ovarian cancer mouse models

Project description:Gene Expression Profiling in high-grade serous ovarian cancer mouse models

2020-07-30 | GSE150640 | GEO